These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Experimental cardiac allograft survival across major histocompatibility complex barriers in the rhesus monkey following T lymphocyte-depleted autologous marrow transplantation. I. In vitro T lymphocyte depletion studies. Moses RD; Orr KS; MacVittie TJ; Gress RE Transplantation; 1988 Aug; 46(2):197-205. PubMed ID: 3043776 [TBL] [Abstract][Full Text] [Related]
43. Two-stage separation of immature and mature T lymphocytes from myeloerythroid clonogenic bone marrow cells by apheresis and elutriation centrifugation. Zucali JR; Weiner RS; Elfenbein GJ; Ashkenazi YJ; Mason RR; Gross MA; Anderson LA; Barth KC Transfusion; 1987; 27(2):148-54. PubMed ID: 2950617 [TBL] [Abstract][Full Text] [Related]
44. Allogeneic bone marrow transplantation with a fixed low number of T-cells in the marrow graft. Jacobs P Blood; 1994 Nov; 84(10):3597-8. PubMed ID: 7949115 [No Abstract] [Full Text] [Related]
45. Application of flow cytometry in the assessment of lymphoid reconstitution following BM transplantation. Fleisher TA Cytotherapy; 1999; 1(4):333. PubMed ID: 20426558 [No Abstract] [Full Text] [Related]
46. Clinical use of irradiated donor lymphocytes in bone marrow transplantation. Ship AM; Waller EK Cancer Treat Res; 1999; 101():267-82. PubMed ID: 10800653 [No Abstract] [Full Text] [Related]
47. Immunological monitoring of bone marrow transplant recipients. I. Major leucocyte subclasses in the blood. Ekblom M; Ruutu T; Volin L; Leskinen R; Renkonen R; Häyry P Scand J Haematol; 1984 Aug; 33(2):113-22. PubMed ID: 6382582 [TBL] [Abstract][Full Text] [Related]
48. Prognostic significance of lymphocyte reconstitution in the early phase after cord blood transplantation. Yuasa M; Asano-Mori Y; Mitsuki T; Yamaguchi K; Kageyama K; Kaji D; Taya Y; Nishida A; Ishiwata K; Takagi S; Yamamoto H; Yamamoto G; Araoka H; Wake A; Makino S; Koike Y; Uchida N; Taniguchi S Br J Haematol; 2021 Apr; 193(2):423-427. PubMed ID: 33751547 [No Abstract] [Full Text] [Related]
49. Rapid separation of whole human bone marrow aspirates by counterflow centrifugation elutriation. Noga SJ; Schwartz CL; Civin CI; Loken M; Donnenberg AD Transplantation; 1987 Mar; 43(3):438-40. PubMed ID: 3547800 [No Abstract] [Full Text] [Related]
50. Effects of acute graft-vs-host disease on the liver of the brown Norway rat. Hightower JA; Earnest DL; Martens AC; Zurcher C; Brouwer A; Blauw E; de Leeuw AM; Hagenbeek A J Leukoc Biol; 1987 Aug; 42(2):128-43. PubMed ID: 3474336 [TBL] [Abstract][Full Text] [Related]
51. Mislabeling of elutriation medium: a demonstration of the need to improve the quality control of reagents produced for cell processing. Stroncek DF; Fautsch S; Burger S; Wagner JE; McCullough J Transfusion; 1995; 35(11):952-4. PubMed ID: 8604494 [TBL] [Abstract][Full Text] [Related]
52. Use of cell affinity chromatography for separation of lymphocyte subpopulations. Hertz CM; Graves DJ; Lauffenburger DA; Serota FT Biotechnol Bioeng; 1985 May; 27(5):603-12. PubMed ID: 18553715 [TBL] [Abstract][Full Text] [Related]
53. Relative superiority of gelatin sedimentation method in enumeration of lymphocyte sub-populations. Kapoor AK; Khan IU; Malhotra S; Mehrotra RM Indian J Med Res; 1980 Feb; 71():303-8. PubMed ID: 7380506 [No Abstract] [Full Text] [Related]
54. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation. Gaschet J; Mahé B; Milpied N; Devilder MC; Dréno B; Bignon JD; Davodeau F; Hallet MM; Bonneville M; Vié H J Clin Invest; 1993 Jan; 91(1):12-20. PubMed ID: 8423212 [TBL] [Abstract][Full Text] [Related]
55. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [TBL] [Abstract][Full Text] [Related]
56. Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation. Haanen C; De Witte T; Plas A; Schattemberg T Haematologica; 1991 Mar; 76 Suppl 1():22-8. PubMed ID: 1864551 [TBL] [Abstract][Full Text] [Related]
57. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies. O'Donnell PV; Jones RJ; Vogelsang GB; Seber A; Ambinder RF; Flinn I; Miller C; Marcellus DC; Griffin C; Abrams R; Braine HG; Grever M; Hess AD; Piantadosi S; Noga SJ Bone Marrow Transplant; 1998 Nov; 22(10):947-55. PubMed ID: 9849691 [TBL] [Abstract][Full Text] [Related]
58. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
59. Using elutriation to engineer bone marrow allografts. Noga SJ; Wagner JE; Rowley SD; Davis JM; Vogelsang GB; Hess AD; Saral R; Santos GW; Donnenberg AD Prog Clin Biol Res; 1990; 333():345-59; discussion 360-1. PubMed ID: 2137932 [TBL] [Abstract][Full Text] [Related]